| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.591 | 0.005 | 0.591 | Cholinergic | 0.462 0.007 CID_27975 | ||
| 0.583 | 0.004 | 0.583 | Acetylcholinesterase inhibitor | 0.49 0.005 CID_27975 | ||
| 0.532 | 0.004 | 0.532 | Butyrylcholinesterase inhibitor | 0.436 0.005 CID_27975 | ||
| 0.491 | 0.034 | 0.491 | Toll-Like receptor agonist | 0.284 0.121 CID_27975 | ||
| 0.446 | 0.007 | 0.446 | Lipid peroxidase inhibitor | 0.254 0.026 CID_27975 | ||
| 0.469 | 0.038 | 0.469 | Toll-Like receptor 7 agonist | 0.262 0.137 CID_27975 | ||
| 0.424 | 0.031 | 0.424 | Antioxidant | 0.418 0.032 CID_27975 | ||
| 0.419 | 0.036 | 0.419 | Spasmolytic | 0.293 0.073 CID_27975 | ||
| 0.445 | 0.067 | 0.445 | Analgesic | 0.277 0.16 CID_27975 | ||
| 0.394 | 0.017 | 0.475 | Anesthetic general | 0.475 0.009 CID_27975 | CID_27975 | |
| 0.435 | 0.059 | 0.435 | Calcium channel L-type activator | 0.424 0.066 CID_27975 | ||
| 0.398 | 0.079 | 0.398 | 5 Hydroxytryptamine release inhibitor | 0.386 0.087 CID_27975 | ||
| 0.352 | 0.039 | 0.576 | Cardiotonic | 0.576 0.009 CID_27975 | CID_27975 | |
| 0.367 | 0.067 | 0.504 | Vasodilator, peripheral | 0.504 0.027 CID_27975 | CID_27975 | |
| 0.401 | 0.113 | 0.401 | Apoptosis agonist | 0.393 0.117 CID_27975 | ||
| 0.294 | 0.017 | 0.333 | Protein kinase stimulant | 0.333 0.013 CID_27975 | CID_27975 | |
| 0.308 | 0.05 | 0.33 | Free radical scavenger | 0.33 0.044 CID_27975 | CID_27975 | |
| 0.273 | 0.024 | 0.273 | MAO inhibitor | 0.104 0.086 CID_27975 | ||
| 0.29 | 0.043 | 0.29 | Anticonvulsant | |||
| 0.3 | 0.057 | 0.394 | DNA damaging | 0.394 0.03 CID_27975 | CID_27975 | |
| 0.29 | 0.052 | 0.504 | Vasodilator | 0.504 0.012 CID_27975 | CID_27975 | |
| 0.239 | 0.014 | 0.431 | Bronchodilator | 0.431 0.005 CID_27975 | CID_27975 | |
| 0.273 | 0.064 | 0.273 | Hypoglycemic | 0.188 0.124 CID_27975 | ||
| 0.245 | 0.041 | 0.271 | Neurotrophic factor enhancer | 0.271 0.028 CID_27975 | CID_27975 | |
| 0.264 | 0.068 | 0.264 | 5 Hydroxytryptamine uptake stimulant | 0.248 0.083 CID_27975 | ||
| 0.212 | 0.027 | 0.212 | MAO A inhibitor | 0.1 0.064 CID_27975 | ||
| 0.283 | 0.102 | 0.38 | Cholesterol antagonist | 0.38 0.054 CID_27975 | CID_27975 | |
| 0.283 | 0.103 | 0.434 | Vasodilator, coronary | 0.434 0.026 CID_27975 | CID_27975 | |
| 0.19 | 0.019 | 0.227 | Adenylate cyclase stimulant | 0.227 0.006 CID_27975 | CID_27975 | |
| 0.214 | 0.043 | 0.214 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.259 | 0.093 | 0.259 | Hypoxia-inducible factor 1 alpha inhibitor | 0.227 0.122 CID_27975 | ||
| 0.182 | 0.018 | 0.182 | Vanilloid 1 agonist | 0.17 0.023 CID_27975 | ||
| 0.192 | 0.029 | 0.276 | Alkylator | 0.276 0.014 CID_27975 | CID_27975 | |
| 0.272 | 0.112 | 0.307 | Transcription factor NF kappa B inhibitor | 0.307 0.091 CID_27975 | CID_27975 | |
| 0.173 | 0.018 | 0.173 | TRPA1 agonist | 0.144 0.036 CID_27975 | ||
| 0.239 | 0.095 | 0.315 | Transcription factor STAT inhibitor | 0.315 0.048 CID_27975 | CID_27975 | |
| 0.206 | 0.065 | 0.269 | Nitric oxide antagonist | 0.269 0.047 CID_27975 | CID_27975 | |
| 0.213 | 0.085 | 0.213 | Hypolipemic | |||
| 0.159 | 0.034 | 0.159 | MAO B inhibitor | |||
| 0.147 | 0.022 | 0.147 | Electron transport complex I inhibitor | 0.133 0.033 CID_27975 | ||
| 0.265 | 0.145 | 0.318 | Histamine release inhibitor | 0.318 0.114 CID_27975 | CID_27975 | |
| 0.199 | 0.08 | 0.275 | Psychostimulant | 0.275 0.05 CID_27975 | CID_27975 | |
| 0.112 | 0.006 | 0.146 | Potassium channel Kv1.3 blocker | 0.146 0.004 CID_27975 | CID_27975 | |
| 0.308 | 0.202 | 0.308 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.161 | 0.059 | 0.161 | CF transmembrane conductance regulator agonist | 0.129 0.121 CID_27975 | ||
| 0.118 | 0.019 | 0.118 | Lipase inhibitor | 0.091 0.033 CID_27975 | ||
| 0.142 | 0.043 | 0.145 | Papain-like protease (SARS coronavirus) inhibitor | 0.145 0.038 CID_27975 | CID_27975 | |
| 0.178 | 0.082 | 0.241 | P-glycoprotein inhibitor | 0.241 0.044 CID_27975 | CID_27975 | |
| 0.218 | 0.123 | 0.218 | Lipoxygenase inhibitor | |||
| 0.114 | 0.026 | 0.114 | Opioid kappa receptor antagonist | 0.088 0.048 CID_27975 | ||
| 0.111 | 0.026 | 0.111 | Analgesic, opioid | 0.093 0.036 CID_27975 | ||
| 0.186 | 0.102 | 0.237 | Potassium channel blocker | 0.237 0.073 CID_27975 | CID_27975 | |
| 0.117 | 0.034 | 0.117 | Phosphodiesterase IV inhibitor | |||
| 0.138 | 0.059 | 0.157 | Cyclooxygenase 3 inhibitor | 0.157 0.043 CID_27975 | CID_27975 | |
| 0.205 | 0.127 | 0.205 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.121 | 0.047 | 0.121 | Xanthine oxidase inhibitor | 0.088 0.074 CID_27975 | ||
| 0.19 | 0.116 | 0.205 | RNA-directed DNA polymerase inhibitor | 0.205 0.093 CID_27975 | CID_27975 | |
| 0.112 | 0.038 | 0.204 | Potassium channel activator | 0.204 0.008 CID_27975 | CID_27975 | |
| 0.174 | 0.103 | 0.182 | Insulin sensitizer | 0.182 0.093 CID_27975 | CID_27975 | |
| 0.08 | 0.009 | 0.08 | Dopamine D3 agonist | 0.037 0.03 CID_27975 | ||
| 0.153 | 0.085 | 0.175 | Arachidonic acid antagonist | 0.175 0.059 CID_27975 | CID_27975 | |
| 0.073 | 0.011 | 0.093 | Adenylate cyclase 1 inhibitor | 0.093 0.005 CID_27975 | CID_27975 | |
| 0.107 | 0.049 | 0.107 | Prolactin inhibitor | 0.086 0.072 CID_27975 | ||
| 0.068 | 0.012 | 0.068 | Cholesterol esterase inhibitor | 0.064 0.014 CID_27975 | ||
| 0.149 | 0.095 | 0.149 | Antipruritic | |||
| 0.193 | 0.144 | 0.193 | Transcription factor STAT3 inhibitor | |||
| 0.156 | 0.108 | 0.156 | Non-steroidal antiinflammatory agent | |||
| 0.097 | 0.05 | 0.097 | Opioid antagonist | 0.076 0.074 CID_27975 | ||
| 0.062 | 0.017 | 0.062 | Opioid kappa receptor agonist | 0.06 0.018 CID_27975 | ||
| 0.114 | 0.071 | 0.125 | Cholesterol synthesis inhibitor | 0.125 0.061 CID_27975 | CID_27975 | |
| 0.08 | 0.037 | 0.08 | Amidase inhibitor | |||
| 0.068 | 0.026 | 0.068 | Acetyl-CoA transferase inhibitor | |||
| 0.053 | 0.014 | 0.053 | Acetyl-CoA transferase 1 inhibitor | |||
| 0.077 | 0.039 | 0.077 | Dopamine agonist | |||
| 0.208 | 0.169 | 0.231 | Apoptosis antagonist | 0.231 0.146 CID_27975 | CID_27975 | |
| 0.073 | 0.036 | 0.079 | Potassium channel (ATP-sensitive) blocker | 0.079 0.029 CID_27975 | CID_27975 | |
| 0.101 | 0.065 | 0.111 | Gastric antisecretory | 0.111 0.052 CID_27975 | CID_27975 | |
| 0.219 | 0.185 | 0.219 | GABA C receptor rho-3 antagonist | |||
| 0.081 | 0.049 | 0.081 | Na+ K+ transporting ATPase inhibitor | 0.079 0.051 CID_27975 | ||
| 0.097 | 0.067 | 0.121 | Anabolic | 0.121 0.039 CID_27975 | CID_27975 | |
| 0.059 | 0.03 | 0.059 | Opioid agonist | 0.048 0.042 CID_27975 | ||
| 0.033 | 0.007 | 0.035 | Vanilloid 2 agonist | 0.035 0.005 CID_27975 | CID_27975 | |
| 0.08 | 0.054 | 0.08 | Acetylcholine nicotinic antagonist | |||
| 0.07 | 0.046 | 0.07 | Opioid mu receptor antagonist | |||
| 0.215 | 0.191 | 0.237 | Calcium channel activator | 0.237 0.163 CID_27975 | CID_27975 | |
| 0.13 | 0.106 | 0.13 | GABA C receptor rho-2 antagonist | |||
| 0.084 | 0.06 | 0.122 | Calcium antagonist | 0.122 0.034 CID_27975 | CID_27975 | |
| 0.063 | 0.04 | 0.063 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.059 | 0.037 | 0.134 | Potassium channel Kv1.5 blocker | 0.134 0.01 CID_27975 | CID_27975 | |
| 0.141 | 0.119 | 0.217 | ATPase inhibitor | 0.217 0.026 CID_27975 | CID_27975 | |
| 0.103 | 0.082 | 0.134 | Adenylate cyclase inhibitor | 0.134 0.056 CID_27975 | CID_27975 | |
| 0.131 | 0.112 | 0.168 | Melanin inhibitor | 0.168 0.061 CID_27975 | CID_27975 | |
| 0.041 | 0.023 | 0.041 | TRPM8 blocker | |||
| 0.026 | 0.01 | 0.026 | CC chemokine 8 receptor antagonist | |||
| 0.065 | 0.05 | 0.065 | 5 Hydroxytryptamine agonist | |||
| 0.057 | 0.042 | 0.057 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.081 | 0.067 | 0.081 | Vanilloid agonist | 0.081 0.068 CID_27975 | ||
| 0.066 | 0.053 | 0.066 | Prostaglandin-E synthase inhibitor | |||
| 0.159 | 0.147 | 0.192 | Immunostimulant | 0.192 0.125 CID_27975 | CID_27975 | |
| 0.101 | 0.088 | 0.101 | Beta amyloid protein antagonist | |||
| 0.184 | 0.172 | 0.184 | Gastrin inhibitor | 0.183 0.174 CID_27975 | ||
| 0.101 | 0.089 | 0.135 | Microtubule formation inhibitor | 0.135 0.047 CID_27975 | CID_27975 | |
| 0.08 | 0.068 | 0.08 | mTOR complex 2 inhibitor | |||
| 0.075 | 0.065 | 0.101 | Glycine receptor antagonist | 0.101 0.032 CID_27975 | CID_27975 | |
| 0.042 | 0.033 | 0.042 | Dopamine D2 agonist | |||
| 0.034 | 0.024 | 0.034 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.027 | 0.018 | 0.027 | Toll-Like receptor 4 agonist | 0.027 0.017 CID_27975 | ||
| 0.114 | 0.106 | 0.149 | Peroxidase inhibitor | 0.149 0.079 CID_27975 | CID_27975 | |
| 0.047 | 0.039 | 0.047 | HCV NS3/NS4A protease inhibitor | |||
| 0.044 | 0.035 | 0.045 | Opioid mu receptor agonist | 0.045 0.034 CID_27975 | CID_27975 | |
| 0.152 | 0.145 | 0.152 | Antiamyloidogenic | |||
| 0.063 | 0.057 | 0.063 | Glutamate (mGluR6) antagonist | |||
| 0.045 | 0.039 | 0.045 | Benzodiazepine antagonist | |||
| 0.096 | 0.091 | 0.106 | Topoisomerase II inhibitor | 0.106 0.08 CID_27975 | CID_27975 | |
| 0.035 | 0.032 | 0.035 | Potassium channel Kv1.1 blocker | |||
| 0.026 | 0.023 | 0.026 | HCV NS5A inhibitor | |||
| 0.132 | 0.131 | 0.645 | Hepatoprotectant | 0.645 0.004 CID_27975 | CID_27975 | |
| 0.082 | 0.083 | 0.087 | Protease inhibitor | 0.087 0.078 CID_27975 | CID_27975 | |
| 0.114 | 0.132 | 0.149 | Growth hormone agonist | 0.149 0.088 CID_27975 | CID_27975 | |
| 0.025 | 0.046 | 0.043 | Cathepsin L2 inhibitor | 0.043 0.027 CID_27975 | CID_27975 | |
| 0.125 | 0.148 | 0.137 | Ca2+-transporting ATPase inhibitor | 0.137 0.087 CID_27975 | CID_27975 | |
| 0.079 | 0.104 | 0.097 | Bile acid receptor antagonist | 0.097 0.056 CID_27975 | CID_27975 | |
| 0.071 | 0.104 | 0.1 | ATPase (Vacuolar H+) inhibitor | 0.1 0.04 CID_27975 | CID_27975 | |
| 0.047 | 0.087 | 0.081 | Antineoplastic antibiotic | 0.081 0.057 CID_27975 | CID_27975 | |
| 0.035 | 0.088 | 0.051 | Potassium channel (Inward rectifier) activator | 0.051 0.034 CID_27975 | CID_27975 | |
| 0.033 | 0.087 | 0.048 | Potassium channel (ATP-sensitive) activator | 0.048 0.033 CID_27975 | CID_27975 | |
| 0.117 | 0.174 | 0.168 | Lipocortins synthesis antagonist | 0.168 0.083 CID_27975 | CID_27975 | |
| 0.226 | 0.283 | 0.283 | Caspase 9 stimulant | 0.283 0.213 CID_27975 | CID_27975 | |
| 0.12 | 0.191 | 0.14 | Heat shock protein 70 antagonist | 0.14 0.075 CID_27975 | CID_27975 | |
| 0.181 | 0.254 | 0.247 | Antibacterial | 0.247 0.179 CID_27975 | CID_27975 | |
| 0.031 | 0.105 | 0.055 | Carbamoyl phosphate synthetase inhibitor | 0.055 0.049 CID_27975 | CID_27975 | |
| 0.131 | 0.206 | 0.183 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.183 0.089 CID_27975 | CID_27975 | |
| 0.059 | 0.139 | 0.085 | Triose-phosphate isomerase inhibitor | 0.085 0.067 CID_27975 | CID_27975 | |
| 0.072 | 0.159 | 0.136 | Alpha-N-acetylglucosaminidase inhibitor | 0.136 0.064 CID_27975 | CID_27975 | |
| 0.067 | 0.162 | 0.094 | Toll-Like receptor 4 antagonist | 0.094 0.08 CID_27975 | CID_27975 | |
| 0.023 | 0.121 | 0.048 | Protein 50S ribosomal subunit inhibitor | 0.048 0.042 CID_27975 | CID_27975 | |
| 0.084 | 0.184 | 0.174 | Amyloid beta aggregation inhibitor | 0.174 0.092 CID_27975 | CID_27975 | |
| 0.133 | 0.249 | 0.219 | Peptidyltransferase inhibitor | 0.219 0.078 CID_27975 | CID_27975 | |
| 0.137 | 0.261 | 0.168 | Nitric-oxide synthase stimulant | 0.168 0.157 CID_27975 | CID_27975 | |
| 0.008 | 0.137 | 0.04 | Leukotriene B4 receptor 2 antagonist | 0.04 0.005 CID_27975 | CID_27975 | |
| 0.14 | 0.27 | 0.24 | Immunosuppressant | 0.24 0.156 CID_27975 | CID_27975 | |
| 0.051 | 0.211 | 0.093 | Lanosterol 14 alpha demethylase inhibitor | 0.093 0.067 CID_27975 | CID_27975 | |
| 0.11 | 0.3 | 0.178 | DNA synthesis inhibitor | 0.178 0.157 CID_27975 | CID_27975 | |
| 0.112 | 0.353 | 0.252 | Sodium/bile acid cotransporter inhibitor | 0.252 0.126 CID_27975 | CID_27975 | |
| 0.025 | 0.756 | 0.577 | Immunomodulator | 0.577 0.014 CID_27975 | CID_27975 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |